Tag: Fate Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Fate Therapeutics Inc

Fate Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded ...

Added to Collection on: 2021-01-08 21:22:30

Tags for this article:

Financial markets
Initial public offering
Finance
Financial economics
Money
Prospectus
Securities Act
Shelf registration
Public offering
Forward-looking statement
SVB Leerink
Two River
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
DAFNA Capital Management LLC Buys Galapagos NV, Cassava Sciences Inc, Dicerna ...

Added to Collection on: 2021-02-16 23:37:30

Tags for this article:

Financial markets
Financial economics
Corporate finance
Stock
Stock market
Dafna
Finance
Dicerna Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc
Immunomedics Inc.
BioCryst Pharmaceuticals Inc.
Kinnate Biopharma Inc.
Fate Therapeutics Inc
Cassava Sciences Inc.
Venus Concept Inc.
Dafna Capital Management Llc
Galapagos NV

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational ...

Added to Collection on: 2021-02-24 21:00:00

Tags for this article:

Clinical medicine
Medicine
Medical specialties
Immune system
Biotechnology
Immunology
Cancer immunotherapy
Lymphoma
Chimeric antigen receptor T cell
Daratumumab
Natural killer cell
Immunotherapy
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Announces Retirement of Chief Scientific Officer after 12 Years of Service

Added to Collection on: 2021-03-25 11:12:53

Tags for this article:

Life Sciences
Biology
Branches of biology
Biotechnology
Stem cells
Induced stem cells
Cell biology
Induced pluripotent stem cell
Biopharmaceutical
Cell therapy
Michel Sadelain
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Is Fate Therapeutics Inc (FATE) a Good Choice in Biotechnology Wednesday?

Added to Collection on: 2021-04-14 14:17:20

Tags for this article:

Stock market
Corporate finance
Stock
Economy
Fate Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress

Added to Collection on: 2021-05-05 19:52:30

Tags for this article:

Clinical medicine
Medical specialties
Medicine
Immune system
Cancer immunotherapy
Natural killer cell
Chimeric antigen receptor T cell
Daratumumab
Antibody-dependent cellular cytotoxicity
Immunotherapy
CD16
Immune checkpoint
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript

Added to Collection on: 2021-05-06 15:00:00

Tags for this article:

Clinical medicine
Branches of biology
Medicine
Orphan drugs
Immune system
Breakthrough therapy
Cancer immunotherapy
Biotechnology
Antibody-dependent cellular cytotoxicity
Natural killer cell
Daratumumab
Chimeric antigen receptor T cell
Wayne Chu
Fate Therapeutics Inc
Scott Wolchko
The Motley Fool

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Added to Collection on: 2024-04-02 20:16:04

Tags for this article:

Induced stem cells
Stem cells
Biotechnology
Developmental biology
Induced pluripotent stem cell
IPSCS
Biopharmaceutical
IPSC
Cellular differentiation
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics (FATE) to Release Quarterly Earnings on Tuesday - Defense World

Added to Collection on: 2025-08-10 09:47:11

Tags for this article:

Pharmaceutical companies
Fate Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics (NASDAQ:FATE) Receives Sell (E+) Rating from Weiss Ratings

Added to Collection on: 2025-10-09 17:55:49

Tags for this article:

Alternative investment management companies
Institutional investors
Capital
Private sector
Stock market
Hedge fund
Fate Therapeutics Inc
Fate Therapeutics

Click the tags to see associated articles and topics

View Article Details
Book a Demo